The program makes most sense for adults who understand that GLP-1 therapy is a gradual, medically supervised process rather than a rapid fix
Abbreviations ACC: American College of Cardiology ADA: American Diabetes Association ASCVD: Atherosclerotic cardiovascular disease BMI: Body mass index CI: Confidence interval CV: Cardiovascular CVD: Cardiovascular disease CVOT: Cardiovascular outcomes trial DPP-4: Dipeptidyl peptidase-4 EASD: European Association for the Study of Diabetes EDTA: European Dialysis and Transplant Association eGFR: Estimated glomerular filtration rate ERA: European Renal Association ESC: Europe Society of Cardiology ESRD: End-stage renal disease EURECA-m: European Renal and Cardiovascular Medicine FDA: U.S
doi: 10.1210/en.2007-1292 Summary Keywords GLP-1, DPP-4, fracture, diabetes, bone, osteoporosis, antidiabetic, glucose-lowering drugs Citation Al-Mashhadi ZK, Viggers R, Fuglsang-Nielsen R, Vestergaard P, Gregersen S and Starup-Linde J (2022) The risk of major osteoporotic fractures with GLP-1 receptor agonists when compared to DPP-4 inhibitors: A Danish nationwide cohort study
Im intrigued to know if this will stay or go